Attachment L-9.2 Retail Vaccine List.docx
DOCX document 38 KB Posted
- Attached to
- DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) Federal contract opportunity
- Solicitation number
- HT940220R0002
- Issued by
- Defense Health Agency
About this file
This notice provides a draft request for proposals for the TRICARE Pharmacy Services, 5th Generation contract. The Defense Health Agency is seeking pharmacy services including retail, mail order, specialty, and care coordination for TRICARE beneficiaries. The anticipated contract would have an 18-month transition period and up to 9 years of total performance including options and an extension. The draft RFP includes sections on contract line item numbers, specialty pharmacy, retail network access, compounded medications, patient safety notifications, and quality control. Interested vendors are invited to review and provide feedback on the draft RFP, with comments due no later than January 17, 2020. The agency estimates issuing a formal solicitation in mid-2020 and hosting an information session on December 11, 2019 to address any questions.
View the file
Other files for this federal contract opportunity
Show all 50
DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) has more files on GovTribe.
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
TPHARM 4 RETAIL VACCINATION PROGRAM_VACCINE LIST_September 2019*
| Vaccine |
| Vaccine description |
| ACIP Abbreviation |
| Trade Name |
| Age Limitation |
MIN
Age Limitation
MAX
| Diphtheria, tetanus and pertussis |
| Diphtheria and tetanus toxoids adsorbed |
| DT |
| Diphtheria and tetanus toxoids adsorbed |
| ≥ 1 month* |
(6 weeks) <7 years
Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed
| DTaP |
| Daptacel, |
Infanrix ≥ 1 month*
<7 years
Tetanus and diphtheria toxoids adsorbed (A)
| Td |
| Tenivac |
| ≥ 7 years |
| none |
Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed
| Tdap |
| Adacel, |
Boostrix
| ≥ 7 years |
| none |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B and inactivated poliovirus vaccine
| DTaP-HepB- IPV |
| Pediarix |
| ≥ 1 month* |
<7 years
Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
| DTaP-IPV |
| Kinrix |
Quadracel
| ≥ 4 years |
| <7 years |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus influenzae type b conjugate vaccine
| DTaP-IPV/Hib |
| Pentacel |
| ≥ 1 month* |
(6 weeks) <7 years
| Vaccine |
| Vaccine description |
| ACIP Abbreviation |
| Trade Name |
| Age Limitation |
MIN
Age Limitation
MAX
Haemophilus influenzae type b
| Haemophilus influenzae type b conjugate vaccine |
| Hib |
| PedvaxHIB; ActHIB |
Hiberix
≥ 1 month* none
| H. influenzae type b, diphtheria, tetanus, pertussis, and polio vaccine |
| DTaP-IPV/Hib |
| Pentacel |
| ≥ 1 month* |
(6 weeks) <7 years
| Hepatitis |
| Hepatitis A vaccine |
| HepA |
| Havrix |
Vaqta
≥ 6 months none
| Hepatitis B vaccine |
| HepB |
| Engerix-B Recombivax HB |
| none |
| none |
Hepatitis B-TLR
| HepB-CpG |
| Heplisav-B |
| ≥ 18 years |
none
| Hepatitis A inactivated and hepatitis B vaccine |
| HepA-HepB |
| Twinrix |
| ≥ 18 year |
| none |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B and inactivated poliovirus vaccine
| DTaP-HepB- IPV |
| Pediarix |
| ≥ 1 month* |
(6 weeks) <7 years
| Herpes zoster |
| Zoster Vaccine Live |
| ZVL |
| Zostavax |
| ≥ 60 years |
| none |
Zoster Vaccine Recombinant, Adjuvanted
RZV
Shingrix
| ≥ 50 years |
| none |
| Vaccine |
| Vaccine description |
| ACIP Abbreviation |
| Trade Name |
| Age Limitation |
MIN
Age Limitation
MAX
| Human papillomavirus |
| Human papillomavirus vaccine |
(9-valent) – types 6,11,16,18,31, 33,45,52,and 58
| 9vHPV |
| Gardasil-9 |
| ≥9 years |
| <27 years |
Influenza
| Live Attenuated Influenza Vaccine, quadrivalent |
| LAIV4 |
| Flumist |
| ≥ 2 years |
| <50 years |
| Trivalent inactivated influenza vaccine |
| IIV3 |
| Afluria |
| ≥ 6 months |
| None |
| Fluad |
| ≥ 65 years |
| None |
| Fluzone High Dose |
| ≥ 65 years |
| None |
Quadrivalent inactivated influenza vaccine
IIV4
| Afluria Quad |
| ≥ 6 months |
| None |
| Fluarix Quad |
| ≥ 6 months |
| None |
| FluLaval Quad |
| ≥ 6 months |
| None |
| Flucelvax Quad |
| ≥ 4 years |
| None |
| Fluzone Quad - MDV |
| ≥ 6 months |
| None |
| Fluzone Quad (Syringe/SDV) |
| ≥ 6 months |
| None |
Fluzone Quad - Ped
| ≥ 6 months |
| None |
| Recombinant Influenza Vaccine, Trivalent |
| RIV3 |
| FluBlok |
| ≥ 18 years |
| None |
| Measles, mumps and rubella |
| Measles, mumps, and rubella vaccine |
| MMR |
| M-M-R II |
| ≥ 6 months |
| None |
| Measles, mumps, rubella, and varicella vaccine |
| MMRV |
| ProQuad |
| ≥1 year |
| None |
| Meningococcal |
| Quadrivalent |
| MenACWY- |
CRM
Menveo
| ≥2 months |
| None |
| Quadrivalent |
| MenACWY- |
D Menactra
| ≥9 months |
| None |
| Serogroup B meningococcal vaccine |
| MenB-FHbp |
MenB-4C Trumenba Bexsero
| ≥10 years |
| none |
| Vaccine |
| Vaccine description |
| ACIP Abbreviation |
| Trade Name |
| Age Limitation |
MIN
Age Limitation
MAX
| Pneumococcal |
| Pneumococcal conjugate vaccine (13-valent) |
| PCV13 |
Prevnar 13
≥ 1 month* none
| Pneumococcal polysaccharide vaccine (23-valent) |
| PPSV23 |
| Pneumovax |
| ≥ 2 years |
| none |
| Poliovirus |
| Inactivated poliovirus vaccine |
| IPV |
| Ipol |
| ≥ 1 month* |
none
Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
| DTaP-IPV |
| Kinrix |
Quadracel
| ≥ 4 years |
| <7 years |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus influenzae type b conjugate vaccine
| DTaP-IPV/Hib |
| Pentacel |
| ≥ 1 month* |
(6 weeks) <7 years
| Rotavirus |
| Rotavirus vaccine (monovalent) |
| RV1 |
| Rotarix |
| ≥ 1 month* |
<9 months
| Rotavirus vaccine (pentavalent) |
| RV5 |
| RotaTeq |
≥ 1 month*
<9 months
| Varicella |
| Varicella vaccine |
| VAR |
| Varivax |
| ≥ 1 years |
| none |
Measles, mumps, rubella, and varicella vaccine
| MMRV |
| ProQuad |
| ≥ 1 years |
| none |
Varicella immune globulin
| VZV |
| VariZIG |
| none |
| none |
*This reference chart is intended to provide vaccine abbreviations and age limitations used in ACIP Recommendations and Policy Notes for routine immunizations (non-routine immunization criteria are not included in this document); published in the MMWR and in the U.S. immunization schedules for children, adolescents, and adults. This information is subject to change.
image1.png
File details come from the government source that posted it. Updated .